Please provide your email address to receive an email when new articles are posted on . He continued, “We wanted to see if it is possible to reduce the dose of adalimumab (by extending the duration ...
Please provide your email address to receive an email when new articles are posted on . Five patients achieved Hidradenitis Suppurativa Clinical Response with 80 mg weekly adalimumab, whereas two ...
Celltrion USA is offering an 80 mg dose of Yuflyma (adalimumab-aaty), a high-concentration (100mg/ml) and citrate-free formulation of Humira (adalimumab) biosimilar, in the United States. Yuflyma is ...
AbbVie’s blockbuster drug Humira has more competition coming—the first FDA-approved biosimilar that may be substituted for the monoclonal antibody at the pharmacy. The competing Boehringer Ingelheim ...
Adalimumab monotherapy and combination with methotrexate showed similar drug survival and PASI75 response rates in plaque psoriasis patients. Methotrexate reduced antidrug antibody levels but did not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results